US2011015088A1PendingUtilityA1
Biocatalytic solgel microarrays
Est. expiryNov 1, 2021(expired)· nominal 20-yr term from priority
B01J 2219/00536B01J 2219/00837B01L 2300/0819B01J 19/0093B01J 2219/0086B01L 2300/069B01J 2219/00585B01J 2219/00722B01J 2219/00596B01L 3/5085B01J 2219/00364B01L 2300/0829B01J 2219/00533B01J 2219/00317B01J 2219/00743B01L 3/5027B01J 2219/0072B01J 2219/00527B01J 2219/00691B01J 2219/00835B01J 2219/00497B01J 19/0046B01J 2219/00725B01J 2219/00644
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A system and method for conducting high-throughput interactions between test compositions and analytes, comprising one or more test compositions, and a plurality of independent micromatrices, wherein each said micromatrix encapsulates at least one said test composition; and said micromatrices are made of a material that is permeable to an analyte.
Claims
exact text as granted — not AI-modified1 . A method for high-throughput screening to detect a reaction or reaction product having a desired feature, comprising the steps of:
a. providing an apparatus, said apparatus comprising a plurality of independent, permeable micromatrices fixed on a solid support, wherein each said micromatrix encapsulates at least one test composition and wherein the test composition is selected from the group consisting of an enzyme, a cofactor, an antibody, a cell extract, a cell fragment and a cell; b. combining one or more distinct applied compositions with said micromatrices under conditions suitable for reacting said applied compositions with said test compositions, wherein each applied composition contains a xenobiotic; and c. assaying each reaction or reaction product in step (b) for a desired feature.
2 . The method of claim 1 , wherein the test composition comprises a constituent of mammalian origin.
3 . The method of claim 2 , wherein the test composition comprises a constituent of human origin.
4 . The method of claim 1 , wherein the test composition is a cell.
5 . The method of claim 1 , wherein the test composition comprises a cytochrome P450 isoform.
6 . The method of claim 1 , wherein the micromatrices are fixed in a well, channel, conduit or depression; or fixed on a raised platform; or surrounded partially or totally by a raised wall or barrier; or surrounded partially or totally by a depressed channel; or a combination thereof.
7 . The method of claim 6 , wherein the micromatrices are surrounded partially or totally by a depressed channel.
8 . The method of claim 6 , wherein the micromatrices are fixed on a raised platform.
9 . The method of claim 1 , wherein a distinct applied composition is combined with a distinct test composition.
10 . The method of claim 9 , wherein numerous distinct applied compositions can be combined with numerous distinct test compositions in parallel.
11 . The method of claim 1 , wherein the applied composition is added to the apparatus by dipping the apparatus into a solution of applied composition.
12 . The method of claim 1 , wherein the product of a reaction is combined with a second test composition.
13 . The method of claim 1 , wherein each said micromatrix is comprised of the same material, wherein said material comprises a solgel, a hydrogel, a polyacrylamide, a polyacrylate, a polyvinyl alcohol, a polyvinylene, or a polyvinyl silicate, and wherein said material is substituted or unsubstituted.
14 . The method of claim 13 , wherein the micromatrices are combined with an applied composition by submerging the micromatrices in a solution comprising the applied composition.
15 . The method of claim 1 , wherein the micromatrices are impermeable to the test composition.
16 . The method of claim 1 , wherein the method is high-throughput.
17 . An apparatus comprising a plurality of independent, permeable micromatrices fixed on a solid support, wherein each said micromatrix encapsulates at least one test composition, wherein the test composition is selected from the group consisting of an enzyme, a cofactor, an antibody, a cell extract, a cell fragment and a cell and wherein the micromatrices are fixed on a raised platform.
18 . The apparatus of claim 17 , wherein the test composition comprises a constituent of mammalian origin.
19 . The apparatus of claim 17 , wherein the test composition comprises a constituent of human origin.
20 . The apparatus of claim of claim 17 , wherein the test composition is a cell.Join the waitlist — get patent alerts
Track US2011015088A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.